Survival after resection of brain metastases with white light microscopy versus fluorescence-guidance: A matched cohort analysis of the Metastasys study data
Survival after resection of brain metastases with white light microscopy versus fluorescence-guidance: A matched cohort analysis of the Metastasys study data |
|
https://doi.org/10.18632/oncotarget.27688
Abdelhalim Hussein,
Veit Rohde,
Christina Wolfert,
Silvia Hernandez-Duran,
Ingo Fiss,
Annalen Bleckmann,
Alonso Barrantes Freer,
Dorothee Mielke,
and Bawarjan Schatlo
|
| 3026-3034 |
Obinutuzumab (GA101) vs. rituximab significantly enhances cell death, antibody-dependent cytotoxicity and improves overall survival against CD20+ primary mediastinal B-cell lymphoma (PMBL) in a xenograft NOD-scid IL2Rgnull (NSG) mouse model: a potential targeted agent in the treatment of PMBL
Obinutuzumab (GA101) vs. rituximab significantly enhances cell death, antibody-dependent cytotoxicity and improves overall survival against CD20+ primary mediastinal B-cell lymphoma (PMBL) in a xenograft NOD-scid IL2Rgnull (NSG) mouse model: a potential targeted agent in the treatment of PMBL |
|
https://doi.org/10.18632/oncotarget.27691
Yaya Chu,
Aradhana Awasthi,
Sanghoon Lee,
Dina Edani,
Changhong Yin,
Jessica Hochberg,
Tishi Shah,
Tae-Hoon Chung,
Janet Ayello,
Carmella van de Ven,
Christian Klein,
Dean Lee,
and Mitchell S. Cairo
|
| 3035-3047 |
Losartan improves the therapeutic effect of metronomic cyclophosphamide in triple negative mammary cancer models
Losartan improves the therapeutic effect of metronomic cyclophosphamide in triple negative mammary cancer models |
|
https://doi.org/10.18632/oncotarget.27694
Leandro E. Mainetti,
María José Rico,
Cintia Daniela Kaufman,
Monica Carolina Grillo,
Julian Guercetti,
María Virginia Baglioni,
Antonela Del Giúdice,
Maria Celeste Capitani,
Matias Fusini,
Viviana Rosa Rozados,
and O. Graciela Scharovsky
|
| 3048-3060 |
Post FDA approval analysis of 200 gallium-68 DOTATATE imaging: A retrospective analysis in neuroendocrine tumor patients
Post FDA approval analysis of 200 gallium-68 DOTATATE imaging: A retrospective analysis in neuroendocrine tumor patients |
|
https://doi.org/10.18632/oncotarget.27695
Aman Chauhan,
Riham El-Khouli,
Timothy Waits,
Rohitashva Agrawal,
Fariha Siddiqui,
Zachary Tarter,
Millicent Horn,
Heidi Weiss,
Elizabeth Oates,
B. Mark Evers,
and Lowell Anthony
|
| 3061-3068 |
Preclinical evaluation of the anti-tumor activity of pralatrexate in high-risk neuroblastoma cells
Preclinical evaluation of the anti-tumor activity of pralatrexate in high-risk neuroblastoma cells |
|
https://doi.org/10.18632/oncotarget.27697
Rachael A. Clark,
Sora Lee,
Jingbo Qiao,
and Dai H. Chung
|
| 3069-3077 |
Important players in carcinogenesis as potential targets in cancer therapy: an update
Important players in carcinogenesis as potential targets in cancer therapy: an update |
|
https://doi.org/10.18632/oncotarget.27689
Justyna Magdalena Hermanowicz,
Iwona Kwiatkowska,
and Dariusz Pawlak
|
| 3078-3101 |
Correction: LRP6 promotes invasion and metastasis of colorectal cancer through cytoskeleton dynamics
Correction: LRP6 promotes invasion and metastasis of colorectal cancer through cytoskeleton dynamics |
|
https://doi.org/10.18632/oncotarget.27710
Qian Yao,
Yu An,
Wei Hou,
Ya-Nan Cao,
Meng-Fei Yao,
Ning-Ning Ma,
Lin Hou,
Hong Zhang,
Hai-Jing Liu,
and Bo Zhang
|
| 3102-3102 |
Correction: Withaferin A (WFA) inhibits tumor growth and metastasis by targeting ovarian cancer stem cells
Correction: Withaferin A (WFA) inhibits tumor growth and metastasis by targeting ovarian cancer stem cells |
|
https://doi.org/10.18632/oncotarget.27597
Sham S. Kakar,
Seema Parte,
Kelsey Carter,
Irving G. Joshua,
Christopher Worth,
Pranela Rameshwar,
and Mariusz Z. Ratajczak
|
| 3103-3104 |
